Introduction {#s0001}
============

The medicinal use of *Podophyllum hexandrum* Royale syn. *P. emodi* Wall (Berberideceae), a high altitude perennial herb native to the alpine and subalpine areas of Himalayas, dates back to ancient times. The plant has been described as 'Aindri' -- a divine drug in the traditional Indian System of Medicine -- the Ayurveda used for the treatment of several ailments including taenia capitis, monocytoid leukaemia, genital warts, constipation, cold, biliary fever, septic wounds, inﬂammation, burning sensation, mental disorder, Hodgkin's and non-Hodgkin's lymphoma (Singh & Shah [@CIT0030]). Podophyllotoxin is the most abundant cyclolignan isolated from podophyllin, a resin produced by species of the genera *Podophyllum*, has cathartic, antirheumatic, antiviral, pesticidal and antimitotic activities (Xu et al. [@CIT0033]; He et al. [@CIT0018]).

Several xenobiotics generally defined as environmental mutagens are of great health concern to the modern man as they induce mutational events, thus posing significant toxicological risks to a myriad of genetic processes (Anand et al. [@CIT0002]). Therefore, the discovery and exploration of compounds possessing antimutagenic and anticarcinogenic properties are gaining credence. Nowadays, the significance of novel bioactive phytocompounds in counteracting the promutagenic and carcinogenic effects are gaining credence.

Antimutagenic activity consists of the suppression of clastogenic processes and can occur by different mechanisms either inside or outside the cell. A variety of genetic tests such as Ames, micronucleus, and chromosomal aberration, have been used to evaluate qualitatively and quantitatively the clastogenic activity of mutagenic compounds (Farah et al. [@CIT0015]; Dar et al. [@CIT0013]). Furthermore, for testing chemicals of human health concern, vertebrate assays have advantage as they are metabolically and physiologically more closely related to the human reactions. Fish act as sentinel organism for indicating the potential for exposure of human population to genotoxic chemicals and subsequently can be used to screen natural products to evaluate their pharmacological activities (Dar et al. [@CIT0010], [@CIT0012]). Fish are frequently used as bioindicators since they are sensitive to changes in their environment and play significant roles in assessing potential risks associated with contamination. Some characteristics of *Carassius carassius* L. (Cyprinidae) such as its wide distribution and availability throughout the year, cost-effectiveness, easy handling and acclimatizing in the laboratory make it an excellent ecotoxicological model. In piscine model, antimutagenic studies are still in infancy and few reports are available. One such report concerns the antimutagenic and anticarcinogenic activity of chlorophyllin towards aflatoxin in rainbow trout (Guha & Khuda-Bukhsh [@CIT0017]). The ameliorating effect of vitamin C, β-carotene and azadirachtin (principle compound of neem) against genotoxicity of ethyl methanesulfonate and cadmium chloride has been demonstrated in a fish, *Oreochromis mossambicus* Peters (Cichlidae) (Ferguson [@CIT0016]). Recently, the antimutagenic effect of neem leaves extract in freshwater fish, *Channa punctatus* Bloch (Channidae) has been evaluated by cytogenetic tests (Farah et al. [@CIT0015]).

The mutagenic and carcinogenic action of various genotoxic substances, like endosulfan, also involves the generation of DNA reactive free radicals, which overcharges the endogenous antioxidant defence systems, characterizing oxidative stress. Thus, in general, some antioxidant agents are capable of retaining the mutagenesis and carcinogenesis (Dar et al. [@CIT0011]). Various methods are used to determine the antioxidant activity; one of the most widely used is the scavenging activity of the stable free radical 2,2-di-phenyl-1-picryl-hidrazila (DPPH), since it is a rapid, reliable and cost effective test (Huang et al. [@CIT0019]).

A large group of mutagens comprises of pesticides and constitute a major risk that give rise to concerns at local, regional, national and global scales (Dar et al. [@CIT0012]). One such compound is endosulfan, a persistent organic pollutant, commercially comprising of two isomers (α- and β-endosulfan) at a ratio of 70:30, belong to the group of chlorinated cyclodienes. Endosulfan is widely used in agriculture around the world to control insect pests and noted for its strong genotoxic effects in various organisms. In our previous studies, we have demonstrated the genotoxicity, clastogenicity and oxidative stress of endosulfan in freshwater fish *C. carassius* (Dar et al. [@CIT0010], [@CIT0012]). Although there are some preliminary reports regarding the antimitotic activity (He et al. [@CIT0018]), there is scanty data regarding the antimutagenic potential of the plant. Therefore, the present study will evaluate the antimutagenic potential of *P. hexandrum*, using piscine model, along with its mechanism of action and identification of bioactive compound(s) and their corresponding benefit to humans.

Materials and methods {#s0002}
=====================

Experimental fish and chemicals {#s0003}
-------------------------------

Healthy fish specimen of *C. carassius*, having chromosome number 100 (2n), were procured in the month of January, 2013 with the help of a local fisherman from the Dal Lake (34°07′N 74°52′E) Srinagar, India. These specimens were identified by Prof. A. R. Yousuf and were transported live in plastic jars to the limnology and fisheries laboratory, University of Kashmir, where they were subjected to a prophylactic treatment by bathing in a 0.05% aqueous solution of potassium permanganate for 2 min to avoid dermal infection. Their average length and wet weight (± SD) were recorded as 12.5 ± 1.6 cm and 33 ± 5 g, respectively. The fish stock was then acclimatized for at least 3 weeks to 1:1 diurnal photoperiod in artificially aerated 60 L glass aquaria (10 fish in each) with aged dechlorinated tap water (pH 7.6--8.4), and fed *ad libitum* daily with commercially available fish food (Feed Royal^®^, Maa Agro Foods, Andhra Pradesh, India). Every effort as suggested by Bennett and Dooley ([@CIT0005]) was taken to maintain optimal conditions during acclimatization: no fish died during this period. The acclimatized fish were used for the experiments, conducted in accordance with the principles of the Institutional Ethical Committee (IEC) for the protection of research animals at the University of Kashmir. Endosulfan, 1,1-diphenyl-2-picryl-hydrazyl (DPPH) and cyclophosphamide were purchased from the Sigma Aldrich, Bengaluru, India. All other chemicals and organic solvents used in the present study were of analytical grade.

Plant material and extraction {#s0004}
-----------------------------

The fresh rhizomes of *P. hexandrum* were collected from the shady and hilly slopes of Dawar, Gurais (34°38′N 74°50′E), Jammu and Kashmir, India in the month of July, 2012. The plant material was authenticated by curator of the Centre of Biodiversity & Taxonomy (CBT), University of Kashmir, India and a voucher specimen (KASH-1752) has been deposited. The rhizomes of *P. hexandrum* were shade dried for 15 days. After being macerated to fine powder, 1 kg rhizome powder was extracted successively with hexane, chloroform, ethyl acetate (EtOAc) and methanol for 16 h using Soxhlet apparatus (Dar et al. [@CIT0009]). The extracts were filtered through a Buchner funnel using Whatman no. 1 filter paper and were concentrated to dryness under vacuum using Heidolph rotary evaporator, yielding 3.4, 71.73, 16.53 and 97.77 g of hexane, chloroform, EtOAc and methanol extracts, respectively. However, 500 g of the residue left after methanol extract was soaked overnight in 500 mL of distilled water at room temperature with constant stirring. Next morning the extract was filtered over muslin cloth and the filtrate was centrifuged at 5000 rpm for 10 min at room temperature. The supernatant was further lyophilized in lyophilizer (Mac-Flow, India) for complete dryness to obtain powder (21.33 g). All the extracts were stored at 4 °C in air tight glass bottles before use.

Fractionation of active extracts {#s0005}
--------------------------------

The active EtOAc and methanol extract of *P. hexandrum* were fractionated using silica gel 60G (0.063--0.200 mm) column chromatography, as per standard procedures (Dar et al. [@CIT0014], [@CIT0008]). Solvents were distilled prior to use. In case of ethyl acetate extract (15 g), column was successively eluted with hexane (2000 mL), hexane:EtOAc \[19:1 (1600 mL), 4:1 (1500 mL), 7:3 (1000 mL), 3:2 (1000 mL), 1:1 (1100 mL) and 3:7 (1300 mL)\] mixtures, EtOAc (3000 mL), EtOAc:methanol \[19:1 (1400 mL), 17:3 (2000 mL) and 7:3 (1100 mL)\] mixtures and methanol (3000 mL). Forty fractions of 500 mL each were collected and combined on the basis of their thin-layer chromatography (TLC) profiles to afford five main fractions. Fractions 1--9, 10--17, 18--24, 25--32 and 33--40 were referred to as EE-F1, F2, F3, F4 and F5, respectively. Similarly, the methanol extract (15 g) loaded column was eluted with the solvent systems of gradually increasing polarity using hexane, chloroform, EtOAc and methanol. The following ratios of solvent combinations were sequentially used in the elution process; pure hexane (2500 mL); hexane:chloroform 95:5, 80:20, 60:40, 40:60 and 20:80 (total solvent 4500 mL); chloroform:EtOAc 95:5, 80:20, 60:40, 40:60 and 20:80 (5500 mL); EtOAc:methanol 95:5, 80:20, 60:40, 40:60, 20:80 and 0:100 (7000 mL). Thirty-nine fractions of 500 mL each were collected and combined on the basis of their TLC profile into five major fractions: fractions 1--7, 8--15, 16--23, 24--30, and 31--39 were referred to as ME-F1, F2, F3, F4 and F5, respectively.

*In vivo* exposure experiment {#s0006}
-----------------------------

The method and procedure recommended by OECD ([@CIT0027]) was followed. The first experiments were semi-static assays consisting of 13 treatments each with 3 replicates, containing 60 L dechlorinated and well-aerated tap water with 10 fish specimens in each aquarium (*n* = 390). Fish were exposed through aqueous medium to each of single sublethal concentration of endosulfan (0.05 mg/L), hexane, chloroform, ethyl acetate, methanol and aqueous extract (15 mg/L each) of *P. hexandrum*, followed by their combination for 96 h. These concentrations were selected on the basis of LC~50~ (0.07 mg/L) value of endosulfan (Dar et al. [@CIT0010]) in *C. carassius*, and optimally high concentrations of *P. hexandrum* extracts were used to ascertain if they had any genotoxic effect. Since endosulfan was an emulsifiable concentrate, it was directly added to the semi-static system, whereas plant extracts were dissolved in 0.5% methanol before adding to the system. The specimen maintained in dechlorinated tap water and those exposed to 0.5% methanol were considered as the negative and solvent control. The specimen maintained in the sublethal concentration of endosulfan served as positive control. The samples were collected at the time intervals of 48, 72 and 96 h and on each sampling interval, 10 fish specimen were sacrificed; 5 fish were processed for the chromosomal aberration (CA) test (0.05% colchicine treatment was given prior to 3 h of autopsy) and the micronucleus assay was carried out from the blood erythrocytes of the rest 5 fish as per standard protocols. In the second set of experiments (*n* = 90), three concentrations of the active extract(s) of plant (5, 10 and 15 mg/L) were used simultaneously with endosulfan (0.05 mg/L) in order to find out the most effective concentration. In the third and final set of experiments (*n* = 300), the column eluted fractions of the most effective concentration of the active extract(s) were used simultaneously with endosulfan, so that the fraction(s) with maximal activity can be identified by various chromatographic and spectroscopic techniques. Furthermore, the mean concentration of endosulfan in the water samples during the experiment was always within 5% of the intended concentration, when analyzed by dispersive liquid--liquid micro-extraction (DLLME) followed by GC-MS ([Supplementary Figure 1](http://dx.doi.org/10.1080/13880209.2016.1233568)).

Micronucleus test {#s0007}
-----------------

Slides were prepared using the standard fish micronucleated erythrocytes method (Al-Sabti & Metcalfe [@CIT0001]). Blood samples were withdrawn by caudal puncture with heparinized syringes and peripheral blood smears were immediately made by applying two drops of blood on precleaned and grease-free slides. The smeared slides were left to air dry at room temperature for overnight in a dust and moisture-free environment. The next day slides were fixed by dipping in cold absolute methanol (4 °C) for 15 min and again left to air dry at room temperature for 1 h. Finally, the slides were stained in May-Grunwald stain for 5--10 min followed with 6% Giemsa in phosphate buffer for 30 min. The slides were then washed thoroughly in double-distilled water, dried and made permanent with DPX-mounting.

For every sampling event, 5 fish were used and replicate slides per fish were prepared. About 1000--1200 cells were examined from each slide, i.e., a minimum of 10,000 erythrocytes were scored, under oil immersion at 100× using Olympus BX 50 microscope (Tokyo, Japan), in each treatment group for the presence of MN. Coded and randomized slides were scored using blind review by a single observer to avoid any technical variation. Only the cells clearly isolated from the surrounding cells were scored.

Chromosomal aberration test {#s0008}
---------------------------

Chromosome preparations were made from the highly hemopoietic and mitotically active head kidney cells, following the standard techniques (Dar et al. [@CIT0010]). The fish of all groups (5 fish/group/exposure) were injected with 0.05% colchicine intramuscularly at 1 mL/100 g body weight 3 h prior to dissection, to arrest the metaphase stage. The head kidney was dissected out, macerated and homogenized in 2 mL of 0.56% KCl, in glass tissue homogenizer, to prepare cell suspension. The cell suspension was poured into Eppendorf tubes and incubated for 20--30 min at room temperature for hypotonic treatment. The cell suspension was fixed in chilled Cornoy's fixative (methanol:glacial acetic-acid, 3:1 v/v), mixed gently with Pasteur pipette, centrifuged at 1500 rpm for 10 min and supernatant was discarded. The pellet was resuspended in chilled Cornoy's fixative and the above process was repeated 3--4 times until the whitish pellet was obtained. Chromosome slides were prepared by dropping one or two drops of cell suspension onto pre-cold slides in 70% alcohol. The slides were then air dried and stained with 5% Giemsa prepared in Sorensen's buffer (pH-6.8) for 20 min. Finally, the slides were cleared in xylene and permanently mounted in DPX.

The slides having brightly stained well-spread metaphase chromosomes were independently coded and observed at 100× under oil immersion with light microscope for chromosomal aberrations. Replicate slides were selected per fish and a minimum of 25 metaphases were scored from each slide in each group including control. Since the number of fish processed per group was five on every exposure time, a total of 250 metaphasic complements were studied. The CA was recorded under two broad categories, i.e., classical aberrations and non-classical aberrations. In the classical aberrations, both chromosome and chromatid type breaks, including acentric fragments, sister chromatid union and multiple aberrations (polyploidy, aneuploidy, rings etc) were counted and non-classical aberration comprised of stickiness, pulverization and c-metaphases.

Scanning electron microscopy (SEM) {#s0009}
----------------------------------

The SEM was carried out by standard procedures (Dar et al. [@CIT0012]). Briefly, the aforementioned micronucleated slides were reshaped, sputter-coated with a gold and platinum to a layer of 3--5 nm and were exclusively examined in the secondary electron mode, at an accelerating voltage of 10 kV, with a scanning electron microscope (JSM6510LV, JEOL, Japan). The images were recorded simultaneously with Digiscan™ hardware and processed with Digital Micrograph 3.4.4 software (Gatan, Inc., Pleasantdon, CA).

Evaluation of antioxidant activity by the DPPH method {#s0010}
-----------------------------------------------------

The antioxidant activity of the active plant fractions and the standard was assessed on the basis of the radical scavenging effect of the stable 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) free radical activity by modified method (Braca et al. [@CIT0007]). The diluted working solutions of the active fractions were prepared in methanol. Rutin was used as standard in 1--100 μg/mL solution. DPPH (0.002%) was prepared in methanol and 1 mL of this solution was mixed with 1 mL of sample solution and standard solution separately. These solution mixtures were kept in dark for 30 min and optical density was measured at 517 nm using UV--Vis spectrophotometer (Shimadzu, Kyoto, Japan). Methanol (1 mL) with DPPH solution (0.002%, 1 mL) was used as blank. The optical density was recorded and % inhibition was calculated using the formula given below (Noipa et al. [@CIT0026]): $$\%\quad\text{Inhibition\ of
DPPH} = \left\lbrack \left( {Abs}_{0} - {Abs}_{1} \right)/{Abs}_{0} \right\rbrack \times 100$$ Where, Abs~0~ = absorbance of control; and Abs~1~ = absorbance of the sample. The experiment was performed in triplicate for each concentration tested.

GC-MS analysis {#s0011}
--------------

GS-MS analysis was carried out with GCMS-QP2010 Plus, Shimadzu, Japan fitted with programmable head space auto sampler and auto injector. The capillary column used was DB-1/RTX-MS (30 m) with helium as a carrier gas, at a flow rate of 3 mL/min with 1 μL injection volume. Samples were analyzed with the column held initially at 100 °C for 2 min after injection, then increased to 170 °C with 10 °C/min heating ramp without hold and increased to 215 °C with 5 °C/min heating ramp for 8 min. Then, the final temperature was increased to 240 °C with 10 °C/min heating ramp for 15 min. The injections were performed in split mode (30:1) at 250 °C. Detector and injector temperatures were 260 °C and 250 °C, respectively. Pressure was established as 76.2 kPa. Run time was 55 min. Temperature and nominal initial flow for flame ionization detector (FID) were set as 230 °C and 3.1 mL/min, correspondingly. MS parameters were as follows: scan range (*m/z*): 40--650 atomic mass units (AMU) under electron impact (EI) ionization (70 eV). The constituent compounds were determined by comparing their retention times and mass weights with those of authentic samples obtained by GC and as well as the mass spectra from the Wiley and Nist database.

Data evaluation and statistical analysis {#s0012}
----------------------------------------

The reduction percentage in number of chromosome aberration and micronuclei in the treatments with the *P. hexandrum* extract(s) was calculated according to the following formula (Waters et al. [@CIT0031]): $$\begin{array}{r}
{{Reduction}\%\quad} \\
{{\quad\quad\quad} = \quad\frac{\text{Frequency
of\ CA\ or\ MN\ in\ A} - {Frequency}\quad{of}\quad{CA}\quad{or}\quad{MN}\quad{in}\quad B}{\text{Frequency\ of\ CA\ or\ MN\ in
A} - \text{Frequency\ of\ CA\ or\ MN\ in
C}}\quad} \\
{{\quad\quad\quad\quad\quad\quad} \times 100} \\
\end{array}$$ Where,A = endosulfan alone; B = Plant extract(s) mixed with endosulfan and C = Negative control (tap water).

Data were compared for statistically significant difference between control and treatment groups using one-way analysis of variance (ANOVA). Significant differences in ANOVA were further analyzed by *post hoc* Bonferroni's, Newman--Keuls and Dunnett's multiple comparison tests.

Results {#s0013}
=======

Antimutagenicity of *P. hexandrum* extracts in chromosome aberration test {#s0014}
-------------------------------------------------------------------------

The typical diploid metaphase complements of the fish, *C. carassius*, were found to consist of 100 chromosomes, belonging to four types, namely, submetacentric, metacentric, subtelocentric and acrocentric. [Table 1](#t0001){ref-type="table"} summarizes the frequency of CA induced by endosulfan and *P. hexandrum* extracts separately and by their simultaneous treatment. The frequency of CA was induced significantly (*p* \< .05) by endosulfan and reached to 7.7 ± 0.37, 9 ± 0.37 and 12 ± 0.47% after 48, 72 and 96 h, respectively. Endosulfan and its simultaneous treatment with hexane, chloroform and aqueous extract were able to produce CA in a significant (*p* \< .05) manner, but the reduction in CA frequency was also observed in case of methanol (71%) and EtOAc (60%) extracts at 96 h, which were further studied in a concentration-dependent manner in order to find out the most effective concentration which came to be 10 and 15 mg/L, respectively ([Table 2](#t0002){ref-type="table"}). The reduction profiles by effective concentration of methanol extract (10 mg/L) with endosulfan were estimated as 63, 65 and 71% for 48, 72 and 96 h, respectively. In the endosulfan group treated with effective concentration of EtOAc extract, the reduction profiles were 45, 50 and 60% for 48, 72 and 96 h, respectively. The highest reduction of 83% versus control after 96 h was recorded, in case of column eluted ME-F2. In the EtOAc group with endosulfan, fraction EE-F4 was found to be more effective as the highest reduction of 73% (0.05 mg/L endosulfan +15 mg/L EE-F4) was recorded after 96 h registering the frequency of 5.71 ± 0.27 compared to 12.14 ± 0.47 of endosulfan (0.05 mg/L) alone ([Table 3](#t0003){ref-type="table"}).

###### 

Frequency profile of CA induced by endosulfan and *P. hexandrum* extracts separately followed by their combination for different time intervals to evaluate the antimutagenicity in *C. carassius*.

                         Classical aberrations   Non-classical aberrations                                 
  ---- ----------- ----- ----------------------- --------------------------- ---- ---- ---- ---- ---- ---- ------------------
  48   Cont. 1     105   1                       1                           --   --   --   --   1    --   2.85 ± 0.21^2^
       Cont. 2     102   1                       1                           --   --   --   --   --   1    2.94 ± 0.16^2^
       ES          117   2                       2                           2    --   1    --   2    --   7.69 ± 0.37^Bb^
       HEPH        114   --                      1                           1    --   --   --   1    1    3.50 ± 0.18^2^
       CEPH        108   1                       2                           --   --   --   --   --   1    3.70 ± 0.23^2^
       EEPH        111   1                       1                           1    --   --   --   1    --   3.60 ± 0.18^2^
       MEPH        100   2                       1                           --   --   --   --   --   --   3.00 ± 0.22^2^
       AEPH        115   1                       1                           --   --   --   --   1    1    3.47 ± 0.18^2^
       ES + HEPH   110   2                       1                           1    1    1    1    1    --   7.27 ± 0.29^Bb^
       ES + CEPH   113   2                       2                           1    --   1    1    2    --   7.96 ± 0.35^Bb^
       ES + EEPH   109   1                       2                           1    --   --   --   1    1    5.50 ± 0.26^Bb2^
       ES + MEPH   103   1                       2                           1    --   --   --   1    --   4.85 ± 0.25^Bb2^
       ES + AEPH   107   1                       2                           1    1    1    --   1    --   6.54 ± 0.28^Bb^
  72   Cont. 1     104   1                       1                           --   --   --   --   1    --   2.88 ± 0.16^2^
       Cont. 2     101   1                       --                          1    --   --   --   1    --   2.97 ± 0.17^2^
       ES          110   2                       2                           1    1    1    --   2    1    9.09 ± 0.37^Bb^
       HEPH        116   1                       1                           1    --   --   --   --   1    3.44 ± 0.18^2^
       CEPH        114   1                       1                           2    --   --   --   --   --   3.50 ± 0.22^2^
       EEPH        113   --                      1                           2    --   --   --   --   1    3.53 ± 0.22^2^
       MEPH        109   1                       1                           1    --   --   --   1    --   3.66 ± 0.18^2^
       AEPH        100   --                      1                           1    --   --   --   1    --   3.00 ± 0.17^2^
       ES + HEPH   106   2                       2                           1    1    1    1    1    --   8.41 ± 0.33^Bb^
       ES + CEPH   112   1                       2                           2    1    1    2    1    --   8.92 ± 0.36^Bb^
       ES + EEPH   117   1                       2                           2    1    --   --   --   1    5.98 ± 0.30^Bb2^
       ES + MEPH   115   2                       1                           1    --   --   1    --   1    5.21 ± 0.25^Bb2^
       ES + AEPH   111   1                       1                           2    2    1    2    --   --   8.10 ± 0.36^Bb^
  96   Cont. 1     119   2                       1                           --   --   --   --   1    --   3.36 ± 0.22^2^
       Cont. 2     108   --                      --                          2    --   --   --   1    1    3.70 ± 0.23^2^
       ES          107   3                       2                           1    1    2    2    1    1    12.14 ± 0.47^B^
       HEPH        108   1                       1                           1    --   --   --   --   1    3.70 ± 0.18^2^
       CEPH        102   --                      1                           2    --   --   --   1    --   3.92 ± 0.24^2^
       EEPH        107   2                       1                           --   --   --   --   --   1    3.73 ± 0.23^2^
       MEPH        105   1                       --                          1    --   --   --   1    1    3.80 ± 0.19^2^
       AEPH        101   1                       2                           1    --   --   --   --   --   3.96 ± 0.24^2^
       ES + HEPH   110   2                       2                           2    2    1    2    1    1    11.81 ± 0.44^Bb^
       ES + CEPH   109   2                       1                           2    2    2    2    1    1    11.92 ± 0.44^Bb^
       ES + EEPH   116   1                       2                           2    1    1    1    --   --   6.89 ± 0.31^Bb2^
       ES + MEPH   113   1                       1                           1    1    1    1    --   --   6.19 ± 0.24^Bb2^
       ES + AEPH   104   2                       2                           2    1    1    1    1    --   9.61 ± 0.38^Bb2^

Exp: exposure time in hours; TMS: total metaphasic plates studied; Csb: chromosome break; Ctb: chromatid break; Frg: fragment; Scu: sister chromatid union; Dic: dicentric; Mla; multiple aberrations; Stp: stickiness and pulverization; Cmt: c metaphase; Cont. 1: negative control (tap water); Cont. 2: solvent control; ES: endosulfan; HEPH; CEPH; EEPH; MEPH and AEPH represent the hexane, chloroform, ethyl acetate, methanol and aqueous extract of *P. hexandrum,* respectively. Values with different upper and lower letter superscripts differ significantly (^Aa^*p* \< .05 = significant; ^Bb^*p* \< .01 = highly significant; ^Cc^*p* \< .001 = extremely significant) from the control 1 and 2, respectively (Newman--Keuls and Dunnett's multiple comparison test), whereas values with different numeric superscripts differ significantly (^1^*p* \< .05 = significant; ^2^*p* \< .01 = highly significant; ^3^*p* \< .001 = extremely significant) from the endosulfan group (Dunnett's multiple comparison test).

###### 

Frequency profile of CA induced alone by endosulfan and in combination with the variable concentrations of the active extracts of *P. hexandrum* for different time intervals to evaluate the concentration-dependent antimutagenic response in *C. carassius*.

                          Classical aberrations   Non-classical aberrations                                 
  ---- ------------ ----- ----------------------- --------------------------- ---- ---- ---- ---- ---- ---- ------------------
  48   Cont. 1      105   1                       1                           --   --   --   --   1    --   2.85 ± 0.21^2^
       Cont. 2      102   1                       1                           --   --   --   --   --   1    2.94 ± 0.16^2^
       Endosulfan   117   2                       2                           1    1    1    --   2    --   7.69 ± 0.37^Bb^
       EE-T1        111   2                       1                           2    1    --   --   --   1    6.30 ± 0.30^Bb^
       EE-T2        104   1                       2                           1    1    1    --   --   --   5.76 ± 0.27^Bb2^
       EE-T3        109   1                       2                           1    --   --   --   1    1    5.50 ± 0.26^Bb2^
       ME-T1        110   --                      1                           2    1    1    1    --   --   5.55 ± 0.26^Bb2^
       ME-T2        108   1                       1                           1    --   --   1    --   1    4.62 ± 0.21^Aa2^
       ME-T3        103   1                       2                           1    --   --   --   1    --   4.85 ± 0.25^Bb2^
  72   Cont. 1      104   1                       1                           --   --   --   --   1    --   2.88 ± 0.16^2^
       Cont. 2      101   1                       --                          1    --   --   --   1    --   2.97 ± 0.17^2^
       Endosulfan   110   2                       2                           1    1    1    --   2    1    9.09 ± 0.37^Bb^
       EE-T1        116   1                       2                           1    1    1    2    --   --   6.89 ± 0.31^Bb2^
       EE-T2        111   1                       1                           1    1    1    2    --   --   6.30 ± 0.27^Bb2^
       EE-T3        112   1                       2                           2    1    --   --   --   1    5.98 ± 0.30^Bb2^
       ME-T1        113   1                       2                           1    1    1    1    --   --   6.21 ± 0.27^Bb2^
       ME-T2        119   2                       1                           1    1    1    --   --   --   5.04 ± 0.25^Ba2^
       ME-T3        115   2                       1                           1    --   --   1    --   1    5.21 ± 0.25^Bb2^
  96   Cont. 1      119   2                       1                           --   --   --   --   1    --   3.36 ± 0.22^2^
       Cont. 2      108   --                      --                          2    --   --   --   1    1    3.70 ± 0.23^2^
       Endosulfan   107   3                       2                           1    1    2    2    1    1    12.14 ± 0.47^Bb^
       EE-T1        117   2                       2                           2    1    1    2    --   --   8.54 ± 0.38^Bb2^
       EE-T2        101   1                       1                           2    1    1    1    1    --   7.92 ± 0.30^Bb2^
       EE-T3        116   1                       2                           2    1    1    1    --   --   6.89 ± 0.31^Bb2^
       ME-T1        107   1                       1                           2    1    1    2    --   --   7.47 ± 0.32^Bb2^
       ME-T2        118   1                       1                           1    1    1    1    1    --   5.93 ± 0.23^Bb2^
       ME-T3        113   1                       1                           1    1    1    1    --   --   6.19 ± 0.24^Bb2^

Exp: exposure time in hours; TMS: total metaphasic plates studied; Csb: chromosome break; Ctb: chromatid break; Frg: fragment; Scu: sister chromatid union; Dic: dicentric; Mla: multiple aberrations; Stp: stickiness and pulverization; Cmt: c metaphase; Cont. 1: negative control (tap water); Cont. 2: solvent control; EE-T1: ethyl acetate extract-treatment 1(0.05 mg/L endosulfan +5 mg/L EE); EE-T2: ethyl acetate extract-treatment 2 (0.05 mg/L endosulfan +10 mg/L EE); EE-T3: ethyl acetate extract-treatment 3 (0.05 mg/L endosulfan +15 mg/L EE); ME-T1: methanol extract treatment 1(0.05 mg/L endosulfan +5 mg/L ME); ME-T2: methanol extract treatment 2 (0.05 mg/L endosulfan +10 mg/L ME); ME-T3: methanol extract treatment 3 (0.05 mg/L endosulfan +15 mg/L ME).

###### 

Frequency profile of CA induced by endosulfan alone and in combination with column eluted fractions of active *P. hexandrum* extracts for different time intervals to evaluate the antimutagenicity in *C. carassius*.

                          Classical aberrations   Non-classical aberrations                                 
  ---- ------------ ----- ----------------------- --------------------------- ---- ---- ---- ---- ---- ---- ------------------
  48   Cont. 1      105   1                       1                           --   --   --   --   1    --   2.85 ± 0.21^2^
       Cont. 2      102   1                       1                           --   --   --   --   --   1    2.94 ± 0.16^2^
       Endosulfan   117   2                       2                           1    1    1    --   2    --   7.69 ± 0.37^Bb^
       EE-F1        103   1                       1                           --   1    1    2    --   --   5.82 ± 0.27^Bb2^
       EE-F2        106   1                       1                           --   1    1    1    --   1    5.66 ± 0.23^Bb2^
       EE-F3        113   1                       1                           2    1    1    --   --   --   5.30 ± 0.26^Bb2^
       EE-F4        101   1                       --                          1    --   --   1    1    1    4.95 ± 0.21^Bb2^
       EE-F5        107   1                       2                           1    1    1    --   --   --   5.60 ± 0.26^Bb2^
       ME-F1        116   1                       1                           1    1    1    1    --   --   5.17 ± 0.22^Bb2^
       ME-F2        118   1                       1                           2    --   --   1    --   --   4.23 ± 0.24^2^
       ME-F3        113   2                       1                           1    --   --   1    --   --   4.42 ± 0.24^A2^
       ME-F4        114   1                       --                          1    1    1    --   1    1    5.26 ± 0.22^Bb2^
       ME-F5        115   1                       2                           2    1    1    --   --   --   6.08 ± 0.30^Bb1^
  72   Cont. 1      104   1                       1                           --   --   --   --   1    --   2.88 ± 0.16^2^
       Cont. 2      101   1                       --                          1    --   --   --   1    --   2.97 ± 0.17^2^
       Endosulfan   110   2                       2                           1    1    1    --   2    1    9.09 ± 0.37^Bb^
       EE-F1        120   1                       1                           1    2    2    --   1    --   6.66 ± 0.31^Bb2^
       EE-F2        100   1                       1                           1    1    1    1    --   --   6.00 ± 0.23^Bb2^
       EE-F3        119   2                       1                           2    --   --   1    1    --   5.88 ± 0.29^Bb2^
       EE-F4        102   1                       --                          1    --   --   1    1    1    4.90 ± 0.21^Bb2^
       EE-F5        108   --                      1                           2    --   --   2    1    1    6.48 ± 0.31^Bb2^
       ME-F1        120   1                       1                           2    --   --   2    1    --   5.83 ± 0.29^Bb2^
       ME-F2        114   1                       1                           1    --   --   1    --   1    4.38 ± 0.20^2^
       ME-F3        107   2                       1                           1    1    1    --   --   --   5.60 ± 0.26^Bb2^
       ME-F4        109   1                       1                           1    --   --   1    1    1    5.50 ± 0.22^Bb2^
       ME-F5        103   1                       2                           1    1    1    1    --   --   6.79 ± 0.28^Bb2^
  96   Cont. 1      119   2                       1                           --   --   --   --   1    --   3.36 ± 0.22^2^
       Cont. 2      108   --                      --                          2    --   --   --   1    1    3.70 ± 0.23^2^
       Endosulfan   107   3                       2                           1    1    2    2    1    1    12.14 ± 0.47^Bb^
       EE-F1        109   1                       1                           2    1    1    1    1    1    8.25 ± 0.33^Bb2^
       EE-F2        111   2                       1                           1    1    1    1    1    --   7.20 ± 0.29^Bb2^
       EE-F3        112   1                       1                           1    2    2    1    --   --   7.14 ± 0.32^Bb2^
       EE-F4        105   1                       1                           2    --   --   1    1    --   5.71 ± 0.27^Bb2^
       EE-F5        106   1                       2                           1    1    1    --   1    1    7.54 ± 0.29^Bb2^
       ME-F1        113   --                      2                           3    --   --   2    --   1    7.07 ± 0.39^Bb2^
       ME-F2        103   --                      1                           2    --   --   1    1    --   4.85 ± 0.25^2^
       ME-F3        104   2                       1                           1    --   --   1    1    1    6.73 ± 0.28^Bb2^
       ME-F4        108   2                       2                           1    --   --   2    --   1    7.40 ± 0.35^Bb2^
       ME-F5        116   1                       2                           1    2    2    --   1    --   7.75 ± 0.35^Bb2^

Exp: exposure time in hours; TMS: total metaphasic plates studied; Csb: chromosome break; Ctb: chromatid break; Frg: fragment; Scu: sister chromatid union; Dic: dicentric; Mla: multiple aberrations; Stp: stickiness and pulverization; Cmt: c metaphase; Cont. 1: negative control (tap water); Cont. 2: solvent control; EE-F1,2,3,4, and 5 designate the ethyl acetate extract fractions 1,2,3,4, and 5 (15 mg/L each), respectively, ME-F1,2,3,4, and 5 represent the methanol extract fractions 1,2,3,4, and 5 (10 mg/L), respectively.

Antimutagenicity of *P. hexandrum* extracts in micronucleus test {#s0015}
----------------------------------------------------------------

The erythrocytes of *C. carassius* were generally observed as elliptical with a centrally located oval nucleus and a considerable amount of cytoplasm, any abnormality could therefore, be seen easily. The size and position of micronucleus in the cytoplasm showed slight variation and normally one MN per cell was observed, though in some instances 2 or 3 MN were also observed at longer duration, when analyzed by SEM, which provides efficient results as compared to simple microscopy.

The frequency of MN induced alone by endosulfan and in combinations with plant extracts is summarized in [Table 4](#t0004){ref-type="table"}. In accordance with the results obtained in CA test, endosulfan induced MN significantly (*p* \< .05) at all durations when used alone, while a clear negative effect on induction of MN by methanol and EtOAc extract was found at all time intervals, with maximum reduction of 69% and 62% at 72 h, respectively. Both these extracts were further studied in a concentration-dependent manner and a concentration of 10 and 15 mg/L came to be effective for methanol and EtOAc extract ([Table 5](#t0005){ref-type="table"}). The reduction profiles in the MN incidence by various column eluted fractions of methanol (ME-1, 2, 3, 4 and 5; 10 mg/L each) with endosulfan were estimated as 54, 74, 67, 50, 26% (48 h); 54, 80, 65, 50, 31% (72 h), and 57, 84, 58, 56, 38% (96 h). Similarly, in the case of endosulfan groups treated with EtOAc fractions (EE-1, 2, 3, 4 and 5; 15 mg/L each), the reduction profiles in the MN incidence were recorded as 46, 54, 58, 61, 42% (48 h); 42, 52, 56, 70, 44% (72 h) and 36, 51, 55, 72, 47% (96 h) ([Table 6](#t0006){ref-type="table"}). Overall, the results revealed that endosulfan was potent genotoxic agent and column eluted fractions ME-F2 and EE-F4 effectively reduced the frequency of CA and MN when used simultaneously with endosulfan.

###### 

Frequency profiles of micronuclei induced alone by endosulfan and *P. hexandrum* extracts followed by their simultaneous exposure for different time intervals to evaluate antimutagenicity in *C. carassius*.

                             Number of MN                    
  ---- ------------ -------- -------------- ----- ---- ----- ------------------
  48   Cont. 1      11,800   28             --    --   28    0.23 ± 0.13^2^
       Cont. 2      11,320   28             1     --   30    0.26 ± 0.13^2^
       ES           12,000   321            21    6    381   3.17 ± 0.83^Bb^
       HEPH         11,490   30             3     --   36    0.31 ± 0.14^2^
       CEPH         11,730   34             4     --   42    0.35 ± 0.15^2^
       EEPH         11,980   31             1     --   33    0.27 ± 0.14^2^
       MEPH         11,670   31             --    --   31    0.26 ± 0.15^2^
       AEPH         11,560   33             1     --   35    0.30 ± 0.16^2^
       ES + HEPH    11,330   334            13    5    375   3.30 ± 0.92^Bb^
       ES + CEPH    11,840   329            15    6    377   3.18 ± 0.87^Bb^
       ES + EEPH    11,648   177            11    2    205   1.75 ± 0.47^Bb2^
       ES + MEPH    11,594   135            9     2    159   1.37 ± 0.36^Aa2^
       ES + AEPH    11,210   321            8     1    340   3.03 ± 0.90^Bb^
  72   Cont. 1      11,550   23             --    --   23    0.19 ± 0.21^2^
       Cont. 2      11,000   30             --    --   30    0.27 ± 0.11^2^
       Endosulfan   11,250   320            35    4    402   3.57 ± 0.89^Bb^
       HEPH         11,990   37             3     --   43    0.35 ± 0.17^2^
       CEPH         11,100   38             5     --   48    0.43 ± 0.18^2^
       EEPH         11,388   35             1     --   37    0.32 ± 0.17^2^
       MEPH         11,715   37             1     --   39    0.33 ± 0.17^2^
       AEPH         11,845   34             --    --   34    0.29 ± 0.16^2^
       ES + HEPH    11,465   337            17    8    395   3.44 ± 0.92^Bb^
       ES + CEPH    11,635   331            23    11   410   3.52 ± 0.89^Bb^
       ES + EEPH    11,585   145            10    2    171   1.47 ± 0.39^Ba2^
       ES + MEPH    11,560   120            16    4    164   1.41 ± 0.32^Ba2^
       ES + AEPH    12,000   271            15    8    325   2.70 ± 0.70^Bb^
  96   Cont. 1      11,980   34             1     --   36    0.30 ± 0.16^2^
       Cont. 2      11,220   36             1     --   38    0.33 ± 0.18^2^
       Endosulfan   11,760   413            116   23   714   6.07 ± 1.11^Bb^
       HEPH         11,068   34             5     --   44    0.39 ± 0.15^2^
       CEPH         11,609   41             3     --   47    0.40 ± 0.19^2^
       EEPH         11,872   38             1     --   40    0.33 ± 0.18^2^
       MEPH         11,039   45             --    --   45    0.40 ± 0.23^2^
       AEPH         11,317   45             2     --   49    0.43 ± 0.22^2^
       ES + HEPH    11,000   421            89    27   680   6.18 ± 1.20^Bb^
       ES + CEPH    11,427   440            99    19   695   6.08 ± 1.22^Bb^
       ES + EEPH    11,005   178            46    15   315   2.86 ± 0.52^Bb2^
       ES + MEPH    11,740   197            33    9    290   2.47 ± 0.52^Bb2^
       ES + AEPH    12,000   386            68    21   585   4.87 ± 1.01^Bb1^

Exp: exposure time in hours; Cont. 1: negative control (tap water); Cont. 2: solvent control; ES: endosulfan (0.05 mg/L); HEPH, CEPH, EEPH, MEPH and AEPH represent the hexane, chloroform, ethyl acetate, methanol and aqueous extract (15 mg/L each) of *P. hexandrum,* respectively.

###### 

Frequency profiles of micronuclei induced alone by endosulfan and in combination with the variable concentrations of the active extracts of *P. hexandrum* for different time intervals to evaluate the concentration-dependent antimutagenic response in *C. carassius*.

                             Number of MN                    
  ---- ------------ -------- -------------- ----- ---- ----- ------------------
  48   Cont. 1      11,800   28             --    --   28    0.23 ± 0.13^2^
       Cont. 2      11,320   28             1     --   30    0.26 ± 0.13^2^
       Endosulfan   12,000   321            21    6    381   3.17 ± 0.83^Bb^
       EE-T1        11,905   203            11    2    231   1.94 ± 0.53^Bb^
       EE-T2        11,730   192            8     3    217   1.84 ± 0.51^Bb1^
       EE-T3        11,648   177            11    2    205   1.75 ± 0.47^Aa1^
       ME-T1        11,560   118            23    7    185   1.60 ± 0.31^Aa2^
       ME-T2        11,670   109            17    4    155   1.32 ± 0.29^2^
       ME-T3        11,594   135            9     2    159   1.37 ± 0.36^2^
  72   Cont. 1      11,550   23             --    --   23    0.19 ± 0.21^2^
       Cont. 2      11,000   30             --    --   30    0.27 ± 0.11^2^
       Endosulfan   11,250   320            35    4    402   3.57 ± 0.89^Bb^
       EE-T1        11,490   200            11    7    243   2.11 ± 0.96^Bb1^
       EE-T2        11,730   121            29    5    194   1.65 ± 0.52^Aa2^
       EE-T3        11,585   145            10    2    171   1.47 ± 0.69^A2^
       ME-T1        11,670   144            19    3    191   1.63 ± 0.66^Aa2^
       ME-T2        11,160   109            12    2    139   1.24 ± 0.52^2^
       ME-T3        11,560   120            16    4    164   1.41 ± 0.55^2^
  96   Cont. 1      11,980   34             1     --   36    0.30 ± 0.16^2^
       Cont. 2      11,220   36             1     --   38    0.33 ± 0.18^2^
       Endosulfan   11,760   413            116   23   714   6.07 ± 1.11^Bb^
       EE-T1        11,490   163            77    16   365   3.17 ± 0.64^Bb2^
       EE-T2        11,730   126            91    26   386   3.29 ± 0.43^Bb2^
       EE-T3        11,005   183            51    10   315   2.86 ± 0.80^Bb2^
       ME-T1        11,670   127            61    21   312   2.67 ± 0.45^Bb2^
       ME-T2        11,560   123            49    17   272   2.35 ± 0.47^Bb2^
       ME-T3        11,740   197            33    9    290   2.47 ± 0.87^Bb2^

Exp: exposure time in hours; Cont. 1: negative control (tap water); Cont. 2: solvent control; EE-T1: ethyl acetate extract-treatment 1(0.05 mg/L endosulfan +5 mg/L EE); EE-T2: ethyl acetate extract-treatment 2 (0.05 mg/L endosulfan +10 mg/L EE); EE-T3: ethyl acetate extract-treatment 3 (0.05 mg/L endosulfan +15 mg/L EE); ME-T1: methanol extract-treatment 1(0.05 mg/L endosulfan +5 mg/L ME); ME-T2: methanol extract-treatment 2 (0.05 mg/L endosulfan +10 mg/L ME); ME-T3: methanol extract-treatment 3 (0.05 mg/L endosulfan +15 mg/L ME).

###### 

Frequency profiles of micronuclei induced by endosulfan alone and in combination with column eluted fractions of active *P. hexandrum* extracts for different time intervals to evaluate the antimutagenicity in *C. carassius*.

                             Number of MN                    
  ---- ------------ -------- -------------- ----- ---- ----- ------------------
  48   Cont. 1      11,800   28             --    --   28    0.23 ± 0.13^2^
       Cont. 2      11,320   28             1     --   30    0.26 ± 0.13^2^
       Endosulfan   12,000   321            21    6    381   3.17 ± 0.83^Bb^
       EE-F1        11,209   181            7     3    204   1.81 ± 0.90^Aa1^
       EE-F2        11,200   136            13    5    177   1.58 ± 0.65^Aa2^
       EE-F3        11,977   140            11    4    174   1.45 ± 0.63^2^
       EE-F4        11,743   138            8     2    160   1.36 ± 0.65^2^
       EE-F5        11,037   184            11    4    218   1.97 ± 0.92^Bb^
       ME-F1        11,410   113            25    6    181   1.58 ± 0.50^Aa2^
       ME-F2        11,080   90             6     3    111   1.00 ± 0.44^2^
       ME-F3        11,635   112            9     3    139   1.19 ± 0.52^2^
       ME-F4        11,094   133            15    9    190   1.71 ± 0.62^Aa1^
       ME-F5        11,595   229            18    5    280   2.41 ± 1.08^Bb^
  72   Cont. 1      11,550   23             --    --   23    0.19 ± 0.21^2^
       Cont. 2      11,000   30             --    --   30    0.27 ± 0.11^2^
       Endosulfan   11,250   320            35    4    402   3.57 ± 0.89^Bb^
       EE-F1        11,715   181            27    6    253   2.15 ± 0.81^Bb1^
       EE-F2        11,940   159            23    4    217   1.81 ± 0.70^Ba2^
       EE-F3        11,107   138            19    4    188   1.69 ± 0.66^Aa2^
       EE-F4        11,333   101            14    3    138   1.21 ± 0.47^2^
       EE-F5        12,000   168            31    7    251   2.09 ± 0.72^Bb1^
       ME-F1        11,820   172            12    3    205   1.73 ± 0.80^Aa2^
       ME-F2        11,440   83             6     1    98    0.85 ± 0.40^2^
       ME-F3        11,255   128            11    2    156   1.38 ± 0.62^2^
       ME-F4        11060    132            30    5    207   1.87 ± 0.60^Bb2^
       ME-F5        11,677   214            29    8    296   2.53 ± 0.97^Bb^
  96   Cont. 1      11,980   34             1     --   36    0.30 ± 0.16^2^
       Cont. 2      11,220   36             1     --   38    0.33 ± 0.18^2^
       Endosulfan   11,760   413            116   23   714   6.07 ± 1.11^Bb^
       EE-F1        11,300   197            101   18   453   4.00 ± 0.79^Bb2^
       EE-F2        11,785   176            76    14   370   3.13 ± 0.69^Bb2^
       EE-F3        11,950   169            71    11   344   2.87 ± 0.66^Bb2^
       EE-F4        11,563   133            35    6    221   1.91 ± 0.57^Aa2^
       EE-F5        11,110   166            79    16   372   3.34 ± 0.70^Bb2^
       ME-F1        11,270   155            65    10   315   2.79 ± 0.64^Bb2^
       ME-F2        11,830   121            7     3    144   1.21 ± 0.56^2^
       ME-F3        11,615   185            53    8    315   2.71 ± 0.79^Bb2^
       ME-F4        11,404   183            56    9    322   2.82 ± 0.78^Bb2^
       ME-F5        11,909   216            98    17   463   3.88 ± 0.84^Bb2^

Exp: exposure time in hours; Cont. 1: negative control (tap water); Cont. 2: solvent control; EE-F1,2,3,4 and 5 designate the ethyl acetate extract fraction 1,2,3,4, and 5 (15 mg/L each), respectively; ME-F1,2,3,4, and 5 represent the methanol extract fraction 1,2,3,4, and 5 (10 mg/L), respectively.

Evaluation of antioxidant activity by the DPPH method {#s0016}
-----------------------------------------------------

The analyses of the antioxidant activity showed that the percentage inhibition of 40 μg/mL of fraction ME-F2 was 81%, which was comparable with the standard antioxidant activity of rutin (85%). However, the free radical scavenging activity of fraction EE-F4 was significantly (45%) debased as compared to the standard ([Figure 1](#F0001){ref-type="fig"}). The potent antioxidant activity of methanolic fraction ME-F2 was confirmed in the present investigation.

![Antioxidant activity of active fractions of *P. hexandrum* expressed as rutin equivalents by the DPPH method.](IPHB_A_1233568_F0001_B){#F0001}

GC-MS analysis {#s0017}
--------------

In order to find out the bioactive compounds responsible for antimutagenic activity, column eluted fractions ME-F2 and EE-F4 were subjected to GC-MS analysis ([Figure 2](#F0002){ref-type="fig"}). ME-F2 showed three major compounds: 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one (30.96%), 2-furancarboxaldehyde, 5-(hydroxymethyl) (28.65%) and hexadecanoic acid, methyl ester (27.07%) constituting 86.68% of the total peak area ([Supplementary Figures 2?4](http://dx.doi.org/10.1080/13880209.2016.1233568)). The minor fractions of ME-F2 include tetradecane (0.45%), 3-deoxy-[d]{.smallcaps}-mannoic lactone (2.08%), 9,12,15-octadecatrienoic acid, methyl ester, (*Z,Z,Z*) (2.16%), deoxy-podophyllotoxin, (2.83%), podophyllotoxin (2.92%), epiisopodophyllotoxin-acetate (0.47%) and 9H-furo\[2,3-H\]chromene-2,8-dione, 4-methyl-9-(3,4,5-trimethoxybenzylidene) (2.34%) comprising 13.32% of the total peak area ([Supplementary Table 1](http://dx.doi.org/10.1080/13880209.2016.1233568)). Six major peaks observed in case of EE-F4 were *n*-hexadecanoic acid (15.47%), (3β)-stigmast-5-en-3-ol (8.62%), d (3β)-stigmasta-5,22-dien-3-ol acetate (9.41%), deoxy-podophyllotoxin (24.22%), podophyllotoxin (18.91) and epiisopodophyllotoxin-acetate (21.13) which constitutes 97.76% of the total peak area ([Supplementary Figures 5?10](http://dx.doi.org/10.1080/13880209.2016.1233568)). Similarly, the minor fractions in case of EE-F4 are (3β)-lanost-8-en-3-ol (1.14%), 16-keto-tetrahydrosolasodine (1.10%) constituting a total ([Supplementary Table 2](http://dx.doi.org/10.1080/13880209.2016.1233568)) peak area of 2.24%.

![TIC chromatogram of the methanol (ME-F2) and ethyl acetate (EE-F4) fraction of *P. hexandrum*. Peaks (A) 1: 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one; 2: 2-furancarboxaldehyde, 5-(hydroxymethyl); 3: hexadecanoic acid, methyl ester. (B) 1: *n*-hexadecanoic acid; 2: (3β)-stigmast-5-en-3-ol; 3: (3β)-stigmasta-5,22-dien-3-ol acetate; 4: deoxy-podophyllotoxin; 5: podophyllotoxin; 6: epiisopodophyllotoxin-acetate; X: minor fractions (detailed in results).](IPHB_A_1233568_F0002_B){#F0002}

Discussion {#s0018}
==========

A good strategy for protection against genetic damage caused by xenobiotics is the intake of compounds, natural or synthetic, capable of preventing the formation or repairing an already induced damage (Aydemir et al. [@CIT0003]). Most of the toxic chemicals that produce genotoxic effects have been known to form reactive oxygen species as well as electrophilic free radical metabolites that interact with DNA to cause disruptive changes (Kim et al. [@CIT0021]). One of our previous studies demonstrated that genotoxic and mutagenic effects of endosulfan were invariably accompanied and correlated with increased oxidative stress and disturbance of antioxidant enzymes (Dar et al. [@CIT0012]). The results of the present study clearly showed that methanol and EtOAc rhizome extracts and fractions of *P. hexandrum* had antimutagenic and anticlastogenic potential. Several mechanisms have been proposed for antimutagenic activity due to the presence of diverse phytochemical constituents such as tannins, saponin, ﬂavonoids, steroids, terpenoids and glycosides (Berhow et al. [@CIT0006]).

The GC-MS analysis of ME-F2 showed that it contains three major bioactive constituents, namely, 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one (DDMP), 2-furancarboxaldehyde, 5-(hydroxymethyl)-(5HMF) and hexadecanoic acid, methyl ester. All these compounds are likely to possess potent antimutagenic activity. The major constituent DDMP present in the ME-F2 is a Millard reaction product of glucose and glycine, having anti-mutagenic activity against arylamine (Berhow et al. [@CIT0006]). This DDMP isolated from onion, in one of the previous studies, have modulated the activity of NF-κB thereby inducing the apoptotic cell death of cancer cells (Ban et al. [@CIT0004]). 5-HMF, which possesses important biological activities like antioxidant, antimyocardial ischemia uterotonic, antiplatelet aggregation and improving hemorheology effects (Luo et al. [@CIT0024]), was also isolated. Ying et al. ([@CIT0034]) also reported that 5-HMF and its derivatives potentially inhibit tumour necrosis factor α or interleukin-1β expression; thus strongly suggesting that 5-HMF might have an exciting antimutagenic potential. Hexadecanoic acid, methyl ester was the third major compound in the ME-F2, and has been reported to possess important biological activities like anti-inflammatory, antioxidant, hypocholesterolemic, 5-α reductase inhibitor, nematicide, antibacterial, antifungal, antiandrogenic, antifibrinolytic, hemolytic, lubricant, nematicide and antialopecic (Praveen et al. [@CIT0028]). Some recent studies have also shown that methyl ester derivatives, including several common aliphatics such as hexadecane, heptadecane, octadecane and eicosane, possess antitumour activity and exhibit potent cytotoxicity in the human cancer screening program (Whelan & Ryan [@CIT0032]). Hexadecanoic acid, methyl ester isolated in this study is a low-molecular weight polymer and is expected to confer a relatively high hydrophilicity to molecules, one factor that might be responsible for the enhancement of cytotoxic effect on tumour cells, justifying its role as a potent antimutagen.

It has been reported that mutation induced by numerous mutagens was reduced by active oxygen scavengers (Kim et al. [@CIT0021]). It has also been suggested that compounds, which possess antioxidant activity, can inhibit mutation and cancer because they can scavenge free radical or induce antioxidative enzyme. Therefore, in order to explore the possible mechanism of action, antioxidant potential of active fractions of *P. hexandrum* was also carried out. The results confirmed that the potent antimutagenic fraction ME-F2 also possess strong antioxidant potential with a strong correlation (*R*^2 ^=^ ^.900) between them. Recently, DDMP, a major compound in ME-F2 fraction, was also isolated and identified as a potent antioxidant from *Pyrus pyrifolia* (Hwang et al. [@CIT0020]), supporting this study and some recent studies which showed a strong correlation between the antioxidant and antimutagenic activity.

The six major compounds identified by GC-MS analysis in the second action fraction EE-F4 were deoxypodophyllotoxin, podophyllotoxin, epiisopodophyllotoxin acetate, palmitic acid, β-sitosterol, and stigmasterol-acetate. Podophyllotoxin and its related derivatives, constituting major percentage of the fraction EE-F4, have been used for a variety of therapeutic purposes including cathartic, antirheumatic and antiviral properties, pesticidal and antimitotic treatments (Xu et al. [@CIT0033]; He et al. [@CIT0018]). Because of its inhibitory activity on cell growth, it is often used as a lead compound for drug design in the search for improved antiproliferative agents. Deoxypodophyllotoxin has antiproliferative, anti-inﬂammatory, antitumour and antiviral activity in diverse cell types (He et al. [@CIT0018]). The free fatty acids (FFAs) were previously described to possess antitumour effects against many different types of human tumour cells, including those from breast, lung and prostate carcinomas, and regression of human gliomas (Reddy et al. [@CIT0029]). Palmitic acid has been reported to induce apoptosis in tumour cells. Many studies have also shown that supplementing the culture medium with palmitic acid completely rescued prostate and breast cancers cells from fatty acid synthase (FAS) knockdown-induced apoptosis (Kwan et al. [@CIT0023]). One molecular target of palmitic acid in tumour cells is DNA topoisomerase I. However, it does not affect DNA topoisomerase II; this suggests that palmitic acid may be a lead compound for anticancer drug discovery. Stigmasterol is known to possess many important biological activities like antihypercholesterolemic, antimutagenic, antileishmanial, antimalarial, antitrypanosomal, platelet aggregation inhibitor and antiviral (Zhou et al. [@CIT0035]). β-Sitosterol is known to be effective against a number of cancers like human breast cancer, colon carcinoma and prostatic cancer (Manayi et al. [@CIT0025]). The significant reduction in the CA and MN in the EE-F4-treated group in our study might be attributed to different mechanism, other than antioxidant potential, of the parent compound podophyllotoxin and needs further study.

Conclusions {#s0019}
===========

In the present work, three novel compounds were identified from the methanol fraction of *P. hexandrum*; biological evaluation showed that most of these compounds exhibited potent antimutagenic activity, via antioxidant pathway, as compared to the already known lignans from the plant and could therefore, potentially be a repository for pharmacologically active products, suitable for the development of new effective chemotherapeutic agents and their corresponding benefit to mankind. This work states the importance of considering these novel identified compounds other than podophyllotoxin and its derivatives in biological studies when using *P. hexandrum* rhizome extracts.
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